Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares Self-Driving EV and Tech (IDRV) vs 10X Genomics Inc (TXG) Price & Performance

iShares Self-Driving EV and TechTrade
10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

iShares Self-Driving EV and Tech vs 10X Genomics Inc — how do they compare? iShares Self-Driving EV and Tech trades at $33.26 (market cap $264.50M), while 10X Genomics Inc trades at $81.65 (market cap $10.07B). The key difference: 10X Genomics Inc is far larger — about 38.1× iShares Self-Driving EV and Tech's market cap, and 10X Genomics Inc is trading nearer its 52-week high, iShares Self-Driving EV and Tech nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares Self-Driving EV and Tech for 73 Days and 10X Genomics Inc for 91 Days on average.

IDRVTXG
Market Cap
$264.50M$10.07B
Volume
48,0215,657,286
Sector
Sector/ThematicHealth
52-Week High
$45.48$97.74
52-Week Low
$32.68$11.48
Typical Hold Time
73 Days91 Days
Enterprise Value
—$9.59B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares Self-Driving EV and Tech

No Aura AI signal available yet.

10X Genomics Inc

10x Genomics (TXG) trades at $82.37, up 8.24% over 24 hours, with a bearish technical signal and mixed analyst sentiment. The company reported a net loss of $43.54M in 2025, but revenue grew to $642.82M, and it has beaten EPS estimates for three consecutive quarters. Recent news highlights strong demand for its Atera platform and a patent victory, though profitability remains a challenge.

The outlook is cautiously optimistic, with growth potential from new product launches and spatial biology demand, but risks include persistent losses, high valuation multiples, and competitive pressures. The consensus price target is $74.30, below the current price, suggesting limited near-term upside.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IDRV

No sentiment data available yet.

TXG
97% Buy3% Sell
Avg holding period · 91 Days

Top news

Latest headlines on both assets

About iShares Self-Driving EV and Tech

IDRV invests in global companies at the forefront of self-driving and electric vehicle innovation. It provides exposure to the full EV value chain, including battery technology and autonomous systems, with top holdings like Albemarle, Rivian, and Tesla.

Read more on IDRV →

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG →